InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（3 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
3
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Hicks Derek, 管理人员. Director active across 1 company, notably Intellia Therapeutics, Inc.. Aggregated, 6 reports have been recorded. Breakdown: 0 buy · 3 sells. Total volume traded: €245k. History available since 3 January 2022. The latest transaction was filed on 3 January 2025 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Hicks Derek
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
6,502 股@ US$12.1831.4% 占其流量Common StockSEC:0000950170-25-003014:0
29,393 股0Common StockSEC:0000950170-24-025903:0
3,877 股@ US$29.4642.5% 占其流量Common StockSEC:0000950170-24-002507:0
23,558 股0Common StockSEC:0001209191-23-015817:0
1,812 股@ US$37.2126.0% 占其流量Common StockSEC:0001209191-23-002421:0
19,118 股0Common StockSEC:0001209191-22-001651:0
6 条申报中的 6 条
About Hicks Derek
Hicks Derek is Dirigeant at Intellia Therapeutics, Inc. (XNAS), where he is EVP, Chief Business Officer. He has 6 filings in total, and the 6 sampled filings, from 2022-01-05 to 2025-01-07, show only sales for EUR 245440.
